Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  Nyse  >  Danaher    DHR

DANAHER (DHR)
Mes dernières consult.
Most popular
Report
Delayed Quote. Delayed  - 01/23 10:02:15 pm
99.95 USD   +0.11%
01/09 DANAHER : CEO To Comment On Financial Performance
01/02 DANAHER : to Present at J.P. Morgan Healthcare Conference
2017 DANAHER : ex-dividend day
SummaryQuotesChartsNewsAnalysisCalendarCompanyFinancialsConsensusRevisions 
News SummaryMost relevantAll newsSector newsTweets

Danaher 1Q Profit Rises 43% On Strong Revenue Growth

share with twitter share with LinkedIn share with facebook
share via e-mail
0
04/19/2012 | 12:54pm CET

Danaher Corp.'s (>> Danaher Corporation) first-quarter earnings rose 43% as the diversified manufacturer's revenue growth got a boost from acquisitions.

For the current quarter, Danaher forecast per-share earnings of 76 cents to 81 cents, including anticipated dilution of a penny from its recent deal to acquire X-Rite Inc. (XRIT). Analysts polled by Thomson Reuters expected per-share earnings of 82 cents.

The company narrowed its 2012 per-share earnings estimate to $3.25 to $3.35 from its previous range of $3.20 to $3.35. The new forecast includes 3 cents of anticipated dilution related to X-Rite.

Danaher has remained acquisitive, mostly focusing its efforts on medical technology, testing and measurement and dental equipment. The acquisition of Beckman Coulter last year for $5.78 billion was Danaher's largest deal and gives the company a stronger foothold in the growing diagnostics industry.

More recently Danaher reached a $478 million deal for color-measurement technology company X-Rite in a move Danaher expects will complement its Esko digital design capabilities and further its lead in the product identification industry.

President and Chief Executive H. Lawrence Culp Jr. said the company was encouraged by the quarter-to-quarter business improvement and expects that core growth will accelerate in the second quarter.

Danaher reported a profit of $612.9 million, or 86 cents a share, up from $429.4 million, or 63 cents a share, a year earlier. Earnings from continuing operations were up at 73 cents from 61 cents. Danaher in January had projected earnings of 66 cents to 71 cents.

Revenue increased 31% to $4.32 billion. Excluding acquisitions and currency fluctuations, revenue was up 1.5%

Analysts recently projected $4.33 billion.

Gross margin fell to 51.8% from 53.1%.

Shares closed Wednesday at $54.69 and were inactive premarket.

-By Tess Stynes, Dow Jones Newswires; 212-416-2481; [email protected]

Stocks mentioned in the article : Danaher Corporation
share with twitter share with LinkedIn share with facebook
share via e-mail
0
Latest news on DANAHER
01/09 DANAHER CORP /DE/ : Results of Operations and Financial Condition, Financial Sta..
01/09 DANAHER : CEO To Comment On Financial Performance
01/06 DANAHER : Montrusco Bolton Investments Has Upped Its Stake in Danaher Del (DHR) ..
01/02 DANAHER : to Present at J.P. Morgan Healthcare Conference
2017 DANAHER : ex-dividend day
2017 DANAHER : Schedules Fourth Quarter 2017 Earnings Conference Call
2017 DANAHER : Initiates 2018 Outlook
2017 DANAHER : Announces Quarterly Dividend
2017 DANAHER : Announces Leadership Appointment
2017 DANAHER : Beckman Coulter Enters Commercial Dispute with Quidel to Sell BNP Dire..
More news
News from SeekingAlpha
01/23 Halma's Model Continues To Drive Value For Shareholders
01/16 DIVIDEND CHALLENGERS (AND NEAR-CHALL : 153 Increases Expected By The End Of Marc..
01/11 COOL, CLEAR WATER : A Thematic Macro Play For The Next Fifty Years
01/10 Danaher (DHR) Presents At 36th Annual J.P. Morgan Healthcare Conference - Sli..
01/09 Recovering End-Markets, Margin Expansion, Potential New Platform Deal Give Co..
Financials ($)
Sales 2017 18 215 M
EBIT 2017 3 395 M
Net income 2017 2 315 M
Debt 2017 9 361 M
Yield 2017 0,54%
P/E ratio 2017 31,83
P/E ratio 2018 28,96
EV / Sales 2017 4,33x
EV / Sales 2018 3,96x
Capitalization 69 526 M
Chart DANAHER
Duration : Period :
Danaher Technical Analysis Chart | DHR | US2358511028 | 4-Traders
Technical analysis trends DANAHER
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 16
Average target price 102 $
Spread / Average Target 2,1%
EPS Revisions
Managers
NameTitle
Thomas Patrick Joyce President, Chief Executive Officer & Director
Stephen M. Rales Chairman
Daniel L. Comas Chief Financial Officer & Executive Vice President
Alan G. Spoon Independent Director
Donald Jerry Ehrlich Lead Independent Director
Sector and Competitors
1st jan.Capitalization (M$)
DANAHER8.34%69 526
INTUITIVE SURGICAL18.91%0
THERMO FISHER SCIENTIFIC12.44%0
BOSTON SCIENTIFIC CORPORATION11.54%0
ILLUMINA11.47%0
EDWARDS LIFESCIENCES9.94%0